PCVX (Vaxcyte, Inc.) Stock Market Reviews

crown

search

Read and share opinions on PCVX (Vaxcyte, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

PCVX

Vaxcyte, Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

TD Cowen Reiterates “Buy” Rating on Vaxcyte (PCVX) With $50 PT
Nov 11, 2025
Bank of America Securities Maintains a Buy Rating on Vaxcyte (PCVX)
Oct 8, 2025
What Does Wall Street Think About Vaxcyte (PCVX)?
Sep 30, 2025
Vaxcyte to Establish Fill-Finish Manufacturing in North Carolina as Key Element of Long-Term United States Commercial Supply Strategy Representing Up to $1 Billion in Manufacturing and Services
Sep 30, 2025
Vaxcyte, Inc. (PCVX)’s VAX-24 Achieves Phase 2 Success in Infants
Jul 31, 2025
Mizuho Maintains an Overweight Rating on Vaxcyte (PCVX)
Jul 16, 2025
Cantor Fitzgerald Maintains Overweight on Vaxcyte Amid Vaccine Development and ACIP Meeting
Jul 2, 2025
Is Vaxcyte, Inc. (PCVX) The Best Stock That Will Bounce Back?
May 9, 2025
Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors
May 1, 2025

Reviews